Author:
Pinkerton C R,Williams D,Wootton C,Meller S T,McElwain T J
Subject
Pediatrics, Perinatology and Child Health
Reference19 articles.
1. Prevention of emesis in patients receiving cytotoxic drugs by GR38032F, a selective 5-HT3 receptor antagonist;Cunningham, D.; Pople, A.; Ford, H.T.;Lancet,1987
2. The efficacy of GR38032F, an antagonist of 5-hydroxytryptamine-3 (5-HT3) in the prophylaxis of cisplatin (CDDP)-induced nausea and vomiting;LD, De Haan; de Mulder PHM; LUAM, Beez;EurJt Cancer Clin Oncol,1988
3. GR38032F: a potent and novel inhibitor of cisplatin-induced emesis in the ferret;Costall, B.; Domeney, A.M.; Gunning, S.J.;Br J Pharmacol,1987
4. First results with ICS 205-930 (5-HT3 receptor antagonist) in prevention ofchemotherapyinduced emesis;Leibundgut, U.; Lancranjan, I.;Lancet,1987
5. Pharmacokinetics and antiemetic efficacy of BRL43694, a new selective 5HT-3 antagonist;Cassidy, J.; Raina, V.; Lewis, C.;BrJ Cancer,1988
Cited by
70 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献